Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells

International Journal of Cancer

Volumn 73, Issue 6, 1997, Pages 880-884

  Ricchi, Paolo ^a,b   Pignata, Sandro ^a,b   Di Popolo, Anna ^a   Memoli, Annamaria ^a   Apicella, Anna ^a   Zarrilli, Raffaele ^a   Acquaviva, Angela M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APOLIPOPROTEIN A1; DNA; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOMEDIN B; SUCRASE; THYMIDINE;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN CACO 2; COLON TUMOR; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; NORTHERN BLOTTING; PATHOLOGY;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOLIPOPROTEIN A-I; APOPTOSIS; ASPIRIN; BLOTTING, NORTHERN; CACO-2 CELLS; CELL DIFFERENTIATION; CELL DIVISION; COLONIC NEOPLASMS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN-LIKE GROWTH FACTOR II; RNA, MESSENGER; S PHASE; SUCRASE; THYMIDINE;

EID: 0031564232     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971210)73:6<880::AID-IJC20>3.0.CO;2-7     Document Type: Article

References (35)

1. CHANTRET, I., BARBAT, A., DUSSAULX, E., BRATTAIN, M.G. and ZWEILBAUM, A., Epithelial polarity, villin expression, and enterocytic differentiation of cullured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res., 48, 1936-1942 (1988).
2. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thyocianate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
3. DAHLQVIST, A., A method of assay of intestinal disaccharidases. Anal. Biochem., 7, 18-25 (1964).
4. DENIZOT, Y., NAJID, A. and RIGAUD, M., Effects of eicosanoid metabolism inhibitors on growth of a human gastric tumor cell line (HGT). Cancer Lett., 73, 65-71 (1993).
5. DEWITT, D. and SMITH, W.L., Yes, but do they still get headaches? Cell, 83, 345-348 (1995).
6. DUBOIS, R.N., AWAD, J., MORROW, J., ROBERTS, L.J. and BISHOP, P.R., Regulation of eicosanoid production and mitogenesis in rut intestinal epithelial cells by transforming growth factor-α and phorbol ester, J. clin. Invest., 93, 493-498 (1994).
7. EBERHART, C.E., COFFEY, R.J., RADHIKA, A., GIARDIELLO, F.M., FERRENBACH, S. and DUBOIS, R.N., Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188 (1994).
8. EBERHART, C.E. and DUBOIS, R.N., Eicosanoids and the gastrointestinal tract. Gastroentology, 109, 285-301 (1995).
9. GIARDIELLO, F.M., HAMILTON, S.R., KRUSH, A.J., PIANTADOSI, S., HYLIND, L.M., CELANO, P., BOOKER, S.V., ROBINSON, C.R. and OFFERHAUS, G.J.A., Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316 (1993).
10. GIOVANNUCCI, E., RIMM, E., STAMPFER, M.G., COLDITZ, G.A., ASCHERIO, A. and WILLETT, W.C., Aspirin use and the risk for colorectal cancer and adenoma in male health professionals, Ann. intern. Med., 121, 241-246 (1994).
11. GOLDBERG, Y., NASSIF, I.I., PITTAS, A., TSAI, L.-L., DYNLACHT, B.D., RIGAS, B. and SHIFF, S.J., The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene, 12, 893-901 (1996).
12. HAKEDA, Y., HOTTA, T., KURIHARA, N., IKEDA, E., MAEDA, N., YAGYU, Y. and KUMEGAWA, M., Prostaglandin El and F2A stimulate differentiation and proliferation, respectively, of clonal osteoblastic MC3T3-EI cells by different second messengers in vitro. Endocrinology, 121, 1966-1974 (1987).
13. HIAL, V., DE MELLO, M.C.F., HORAKOVA, Z. and BEAVEN, M.A., Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines. J. Pharmacol. exp. Ther., 202, 446-454 (1977).
14. HUBBARD, W.C., ALLEY, M.C., MCLEMORE, T.L. and BOYD, M.R., Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate and ovarian tumors. Cancer Res., 48, 4770-4775 (1988).
15. KUTCHERA, W., JONES, D.A., MATSUNAMI, N., GRODEN, J., MCINTYRE, T.M., ZIMMERMAN, G.A., WHITE, R.L. and PRESCOTT, S.M., Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. nat. Acad. Sci. (Wash.), 93, 4816-4820 (1996).
16. LEE, D.Y., LUPTON, J.R. and CHAPKIN, R.S., Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. Prostaglandins, 43, 143-164 (1992).
17. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with the Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
18. MEADE, E.A., SMITH, W.L. and DEWITT, D., Differential inhibition of prostaglandin encloperoxide synthase (cyclooxygenase) by aspirin and other non-steroidal anti-inflammatory drugs. J. biol. Chem., 268, 6610-6614 (1993).
19. NUGENT, K.P., FARMER, K.C., SPIGELMAN, A.D., WILLIAMS, C.B. and PHILLIPS, R.K., Randomized controlled trial on the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Brit. J. Surg., 80, 1618-1619 (1993).
20. O'BANION, M.K., SADOWSKY, H.B., WINN, V. and YOUNG, D.A., A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J. biol. Chem., 270, 3239-3246 (1991).
21. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809 (1996).
22. PASRICHA, P.O., BEDI, A., O'CONNOR, K., RASHID, A., AKHTAR, A.J., ZAHURAK, M.L., PIANTADOSI, S., HAMILTON, S.R. and GIARDIELLO, F.M., The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109, 994-998 (1995).
23. PIAZZA, G.A., THOMPSON, H.G., MEHTA, R.G., ALBERTS, D.S., BURT, R.W., PAMUKCU, R. and AHNEN, D.J., Mechanism for the antineoplastic properties of sulindac metabolites. Int. J. Oncol., 1, 962 (1995).
24. PIGNATA, S., MAGGINI, L., ZARRILLI, R., REA, A. and ACQUAVIVA, A.M., The enterocyte-like differentiation of the Caco-2 cell line strongly correlates with responsiveness to cAMP and activation of kinase A pathway. Cell Growth Differ., 5, 967-973 (1994).
25. PINTO, M., ROBINE-LEON, S., APPAY, M.D., KEDINGER, M., TRIADOU, N., DUSSAULX, E., LACROIX, B., SIMON-ASSMANN, P., HAFFEN, K., FOGH, J. and ZWEIBAUM, A., Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. (Paris) 47, 323-330 (1983).
26. RUMBLE, R.H. and ROBERTS, M.S., Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction. J. Chromatogr., 225, 252-260 (1981).
27. SAWADA, M., SUZUMURA, A., OHNO, K. and MARUNOUCHI, T., Regulation of astrocyte proliferation by prostaglandin E2 and the a subtype of protein kinase C. Brain Res., 613, 67-73 (1993).
28. SCHROY, P.C., RUSTGI, A.K., IKONOMU, E., LIU, X.P., POLITO, J., ANDRY, C. and O'KEANE, J.C., Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J. cell. Physiol., 161, 111-123 (1994).
29. SHIFF, S.J., KOUTSOS, M.I., QIAO, L. and RIGAS, B., Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effect on cell cycle and apoptosis. Exp. Cell Res., 222, 179-188 (1996).
30. SHIFF, S.J., QIAO, L., TSAI, L.L. and RIGAS, B., Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. clin. Invest., 96, 491-503 (1995).
31. THUN, M.J., NAMBOODIRI, M.M. and HEALTH, C.W., JR., Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 328, 1509-1513 (1991).
32. TSUJII, M. and DUBOIS, R.N., Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501 (1995).
33. VANE, J,. Toward a better aspirin. Nature (Lond.), 365, 215-216 (1994).
34. ZARRILLI, R., PIGNATA, S., ROMANO, M., GRAVINA, A., CASOLA, S., BRUNI, C.B. and ACQUAVIVA, A.M., Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of Caco-2 human colon carcinoma cells. Cell Growth Differ., 5, 1085-1091 (1994).
35. ZARRILLI, R., ROMANO, M., PIGNATA, S., CASOLA, S., BRUNI, C.B. and AQUAVIVA, A.M., Constitutive insulin-like growth factor-II expression interferes with the enterocyte-like differentiation of Caco-2 cells. J. biol. Chem., 271, 8108-8114 (1996).